The Patent Finder
US

Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer

US 10,738,108 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jan 31, 2027 · High confidence

Filed Sep 20, 2017 as application 15/710,252 · Granted Aug 11, 2020
Base term plus 268 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2006 2027
Clock starts
Nov 24, 2006
Term ends
Jan 31, 2027
Granted
Aug 11, 2020
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
268
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,017,564, US 10,174,104, US 8,168,427, US 9,212,228, US 9,751,934.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 268 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 1 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 24, 2006, when application PCT/EP2006/011302, the earliest non-provisional in its chain, was filed (this one was filed Sep 20, 2017)Nov 24, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+268 days, USPTO patent term adjustment recordAug 19, 2027High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,017,564, US 10,174,104, US 8,168,427, US 9,212,228, US 9,751,934)capped to Jan 31, 2027High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 1 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 31, 2027High confidence

This family

US 8,168,427In force
Feb 2028
Feb 2028
US 9,499,609In force
Dec 2028
Dec 2028
US 9,212,228In force
Feb 2028
Feb 2028
US 10,174,104In force
Mar 2027
Mar 2027
US 9,751,934In force
Feb 2027
Feb 2027
US 10,017,564In force
Jan 2027
Jan 2027
US 10,738,108this patent
Jan 2027
Jan 2027
US 11,739,139In force
Jan 2027
Jan 2027
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 20, 2017
Reel 43924, frame 704
Sahin, Ugur; Tureci, Ozlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-gerhard; Schroder, Anja Kristina; Thiel, PhilippeGanymed Pharmaceuticals AG; Johannes Gutenberg-Universitat MainzAssignment of Assignor's Interest
Sep 20, 2017
reel/frame not recorded
Brandenburg, Gunda; Sahin, Ugur; Tureci, Ozlem; Geppert, Harald-gerhard; Usener, Dirk; Fritz, Stefan; Thiel, Philippe; Uherek, Christoph; Schroder, Anja KristinaGanymed Pharmaceuticals AGAssignment of Assignor's Interest
Sep 20, 2017
reel/frame not recorded
Brandenburg, Gunda; Sahin, Ugur; Tureci, Ozlem; Geppert, Harald-gerhard; Usener, Dirk; Fritz, Stefan; Thiel, Philippe; Uherek, Christoph; Schroder, Anja KristinaJohannes Gutenberg-Universitat MainzAssignment of Assignor's Interest
Apr 11, 2019
Reel 48876, frame 682
Ganymed Pharmaceuticals AGGanymed Pharmaceuticals GmbHChange of Name
Apr 15, 2019
Reel 48889, frame 292
Ganymed Pharmaceuticals GmbHAstellas Pharma Inc.Assignment of Assignor's Interest
Apr 25, 2019
Reel 49001, frame 723
Johannes Gutenberg-Universitat MainzTron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbHAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited